Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
TheBody.com/The Body PRO Covers IAS 2009, July 19-22, 2009
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
Press Release

Scientists Warn Against Retrenchment on AIDS

As 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention Opens, Leaders Urge Continued Momentum Towards Universal Access in Africa and Globally

July 19, 2009

Cape Town, South Africa -- Amidst a lingering global recession and indications that world leaders are retreating on previous commitments to universal access to HIV prevention and treatment, the more than 5,000 AIDS researchers, implementers and community leaders gathered in Cape Town for the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) warned of dire public health consequences resulting from a retrenchment on the global fight against AIDS. This warning came at the opening of IAS 2009, a biennial scientific meeting organized by the International AIDS Society (IAS) in partnership with Dira Sengwe.

Dr. Julio Montaner
Dr. Julio Montaner

"Despite the recession, the global response to HIV -- including the commitment of sufficient resources to achieve universal access to HIV prevention and treatment, fully fund AIDS research and strengthen underlying health systems -- cannot be put in a holding pattern," said IAS President Dr. Julio Montaner, who is IAS 2009 Chair and Director of the BC Centre for Excellence in HIV/AIDS in Vancouver, Canada. "If we don't move forward, we will rapidly lose ground. That is the reality we face at this pivotal moment in HIV scale-up," he added.

"For IAS 2009 Local Co-Chair Dr. Hoosen (Jerry) Coovadia, the conference is taking place at the right time and place. "Without a doubt, AIDS occupies a pivotal position in South Africa's history, having helped to frame our country's political, social and economic life in the post-apartheid era," he said. "With reports of interruptions in drug supply and shortages here and elsewhere foremost on our minds, we must ensure that health delivery systems on our continent are effective and adequately funded in order to prevent needless deaths and countless preventable infections," he added. Dr. Coovadia is Chairman of Dira Sengwe and Scientific Director of the Doris Duke Medical Research Institute at the University of KwaZulu-Natal in Durban.

Advertisement
The IAS Conference series focuses on the translation of research into practice, particularly in low- and middle-income countries. This emphasis is further reflected this year by the addition of a new conference track on operations research, which involves the ongoing evaluation of programme implementation to strengthen service delivery and identify best practice. The notion of "learning by doing" will be the focus of a number of conference sessions.

Opening Programme

The emphasis on the real-world application of science was also reflected in today's opening session, which began with welcoming remarks by the conference Co-Chairs and South Africa's Deputy President Kgalema Motlanthe, followed by a community welcome by Viyuseka Dubula, General Secretary of the Treatment Action Campaign in South Africa. In her remarks, Ms. Dubula highlighted progress and challenges since the XIII International AIDS Conference took place in Durban in 2000, an event that is widely credited with having focused global attention on geographic disparities in HIV treatment and jumpstarting the move to expand access in low-income countries.

The opening session also featured a scientific keynote address by 2008 Nobel Laureate and IAS Governing Council member Professor Françoise Barré-Sinoussi entitled, Can the Establishment and Persistence of HIV Reservoirs Ever be Controlled? Viral reservoirs -- hidden mostly in subpopulations of latently infected resting memory CD4+ T cells -- constitute the major obstacle to eliminating HIV from the body. In her remarks, Prof. Barré-Sinoussi explained how HIV persists in patients treated with highly active antiretroviral therapy and posed some of the most vexing questions facing AIDS scientists and clinicians today, including: What are the main reservoirs of HIV in the body? What are the mechanisms responsible for their establishment and persistence? Which strategies can be proposed accordingly?

AIDS Free World Co-Director Stephen Lewis gave a second keynote address entitled, Scientists as Activists. Mr. Lewis argued that what is desperately needed today is unrelenting and informed voices of advocacy, and he called upon the scientific community to use both their scientific expertise and their voices to respond to the pandemic.

A webcast of the opening session will be available on the conference Web site as of late Sunday.

Programme to Highlight Other Key Research and Implementation Issues

"IAS 2009 will explore issues at the top of the AIDS research and policy agendas, including: the impact of HIV-specific funding on broader efforts to strengthen health systems; disparities in normative guidelines on when to start HIV treatment for people living in the global North versus the South; and the emerging concept of treatment as prevention, which recognizes the added preventive value of antiretroviral therapy. Four special sessions will examine other key issues:

  • Scaling up Biomedical Prevention and Treatment Interventions -- The Critical Role of Social Science, Law and Human Rights (Monday, 20 July, 13:00)
  • U.S. Global HIV Policy, Research and Implementation Under a New Administration, featuring NIAID Director Anthony Fauci and newly confirmed U.S. Global AIDS Coordinator Eric Goosby (Monday, 20 July, 13:00)
  • What Have We Learned from DART (Development of AntiRetroviral Therapy in Africa)? (Tuesday, 21 July, 07:00)
  • Drug and Alcohol Dependence -- New Advances and Ongoing Challenges in HIV Treatment and Prevention (Tuesday, 21 July, 13:00)

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by International AIDS Society. It is a part of the publication The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Visit International AIDS Society's website to find out more about their activities, publications and services.
 
See Also
IAS 2009 Newsroom



Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement